Thirunavukkarasu Angappan: The Global Shift Toward Plasma Self-Sufficiency
Thirunavukkarasu Angappan, Vice President of Operations and Manufacturing at PopVax, shared a post on LinkedIn:
“Plasma Self-Sufficiency Just Became Corporate Strategy, Not Just Policy
For years, plasma self-sufficiency was mostly something governments talked about.
Over the last 18 months, it’s become something companies are actually building toward – and Grifols is the clearest example.
November 2025: Grifols bought a majority stake (50.1%) in a Canadian plasma-collection company, strengthening its control over plasma sourced in Canada.
December 2025, one month later: Grifols received EU (EMA) certification for its entire Egyptian plasma operation – a joint venture that turns local Egyptian plasma into medicines approved for sale across Europe.
This made Egypt the first country in Africa or the Middle East with this level of certification.
Later, in April 2026: Grifols closed 29 of its US donation centers, while also preparing to spin off and IPO a separate, self-sufficient US Biopharma business.
Context: Roughly 40% of Europe’s plasma supply has historically come from the United States.
Building EU-certified plasma capacity in Egypt and Canada isn’t just expansion – it’s a hedge against that US dependence, timed to a plasma market still growing at a high single-digit rate every year.
Will other major plasma companies follow Grifols toward building their own regional, self-sufficient supply chains – or does scale still favor staying consolidated around a few very large, centralized sourcing hubs?”

Stay updated with Hemostasis Today.
-
Aug 19, 2026, 12:59David McIntosh: The Growing Global Demand for Plasma-Derived Therapies
-
Aug 19, 2026, 12:55Maia Meier: When a Rare Bleeding Disorder Changes a Family’s Journey
-
Aug 19, 2026, 12:45Melissa Hollo: Impact of Anemia on Surgical Outcomes
-
Aug 19, 2026, 12:40Wolfgang Miesbach: The Growing Impact of Age-Related Disease in Hemophilia
-
Aug 19, 2026, 09:12Charlie Berman: Infections Following Mechanical Thrombectomy for Acute Stroke
-
Aug 19, 2026, 08:39Choosing the Right P2Y12 Inhibitor After PCI – JAMA Cardiology
-
Aug 19, 2026, 08:05Charles Cohen: Why Women Wait Years Longer for a Bleeding Disorder Diagnosis
-
Aug 19, 2026, 07:42Chukwuemeka Amarachi: Thalassemia – Types, Diagnosis and Management
-
Aug 19, 2026, 07:15Ajay Kumar: Real-World Outcomes of Plasma Exchange in NMOSD